Valuation: EUROAPI

Market Cap 74.51M 85.45M 70.36M 63.89M 120M 8.2B 120M 843M 325M 4.17B 321M 314M 13.41B P/E 2026 *
-0.61x
P/E 2027 * -1.49x
Enterprise Value 93.8M 108M 88.56M 80.42M 151M 10.32B 151M 1.06B 409M 5.25B 404M 395M 16.88B EV / Sales 2026 *
0.12x
EV / Sales 2027 * 0.18x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day-17.33%
1 week-17.33%
Current month-17.33%
1 month-17.33%
3 months-35.95%
6 months-23.84%
Current year-63.22%
1 week 0.97
Extreme 0.9672
0.97
1 month 0.97
Extreme 0.9672
0.97
Current year 0.97
Extreme 0.9672
2.54
1 year 0.97
Extreme 0.9672
3.59
3 years 0.97
Extreme 0.9672
12.25
5 years 0.97
Extreme 0.9672
23.4
10 years 0.97
Extreme 0.9672
23.4
Manager TitleAgeSince
Chief Executive Officer - 09/12/2024
Director of Finance/CFO - 17/10/2024
Compliance Officer - 27/11/2023
Director TitleAgeSince
Director/Board Member 62 06/05/2022
Director/Board Member - 06/05/2022
Chairman 57 09/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-17.33%-17.33% - - 85.45M
+0.04%+3.34%+51.12%+101.82% 1,028B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 466B
-1.22%+3.66%+36.44%+38.32% 346B
-0.79%+2.73%+19.03%+25.08% 266B
+0.58%+6.76%+11.13%+16.52% 259B
+1.55%+2.20%+39.81%+46.55% 208B
+0.79%+1.84%-28.27%-56.71% 191B
-0.52%+4.45%+32.12%+98.51% 186B
Average -1.55%+3.26%+26.15%+45.30% 400.19B
Weighted average by Cap. +0.23%+3.09%+35.15%+61.76%

Financials

2026 *2027 *
Net sales 753M 863M 711M 645M 1.21B 82.84B 1.21B 8.51B 3.29B 42.12B 3.24B 3.17B 136B 760M 872M 718M 652M 1.22B 83.66B 1.23B 8.6B 3.32B 42.54B 3.28B 3.2B 137B
Net income -122M -139M -115M -104M -195M -13.38B -196M -1.38B -531M -6.8B -524M -512M -21.89B -50.07M -57.41M -47.27M -42.93M -80.43M -5.51B -80.77M -566M -219M -2.8B -216M -211M -9.01B
Net Debt 19.28M 22.11M 18.21M 16.53M 30.98M 2.12B 31.11M 218M 84.17M 1.08B 83.07M 81.23M 3.47B 61.91M 71M 58.46M 53.08M 99.46M 6.81B 99.87M 700M 270M 3.46B 267M 261M 11.14B
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.7800EUR
Average target price
1.150EUR
Spread / Average Target
+47.44%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!